Table 5.
Binary logistics regression analysis with pregnancy and birth outcomes as the influencing factor.
| starting dose of rhFSH | Crude model | Adjusted model | |||
|---|---|---|---|---|---|
| OR (95% CI) | P-value | OR (95% CI) | P-value | ||
| Positive pregnancy | 150 IU | Reference | Reference | ||
| 225 IU | 1.065 (0.749-1.514) | 0.725 | 1.02 (0.711-1.464) | 0.915 | |
| Clinical pregnancy | 150 IU | Reference | Reference | ||
| 225 IU | 1.103 (0.775-1.57) | 0.585 | 1.074 (0.748-1.542) | 0.699 | |
| Ongoing pregnancy | 150 IU | Reference | Reference | ||
| 225 IU | 1.066 (0.748-1.52) | 0.724 | 1.036 (0.719-1.491) | 0.85 | |
| Live birth | 150 IU | Reference | Reference | ||
| 225 IU | 1.065 (0.743-1.524) | 0.733 | 1.043 (0.721-1.51) | 0.822 | |
CI, confidence interval.
Analyses were adjusted for age, BMI, AMH, infertility type (primary or secondary), starting dose of rhFSH, ovulation trigger protocol, total dose of Cetrorelix.